This activation leads to increased insulin production, reduced appetite, and support for weight loss
The lines in my forehead gone
They promise to play an important role in future treatments and tools that aid in detection and diagnosis
They are not intended to diagnose, treat, cure, or prevent any disease.
Homozygous mutations may result in more significant disruptions in methylation
Further reading FcRn blockade in CIDP (ADHERE trial) The Lancet Neurology 2024 #PatientEducation #CIDP #Neuromuscular #EvidenceBasedMedicine Safety, tolerability, and efficacy of subcutaneous efgartigimod in patients with chronic inflammatory demyelinating polyradiculoneuropathy (ADHERE): a multicentre, randomised-withdrawal, double-blind, placebo-controlled, phase 2 trial thelancet.com To view or add a comment, sign in Platelet Hyperreactivity: A Novel Peripheral Biomarker for Preclinical Alzheimers